-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-Cumberland Pharmaceuticals And Vanderbilt Announce Phase 2A Trial Data For ifetroban In High-Risk Solid Tumors

Reuters·06/02/2026 13:13:34

Please log in to view news